Ionis cuts Tryngolza 2026 sales guidance, highlights Zanvastro launch and new Phase 3 winsNov 9Quarterly updateIonis PharmaceuticalsolezarsenUpdated
Roche reports Phase 3 data showing sefaxersen cut proteinuria in IgA nephropathyOct 23Clinical readoutIonis PharmaceuticalsRoche
Ionis and Roche report positive Phase 3 interim data for sefaxersen in IgA nephropathySep 23Clinical readoutIonis PharmaceuticalsRoche